Democritus University of Thrace (DUTH)
Μεταβολισμός και ενεργειακό περιβάλλον σε φλεγμονώδεις καταστάσεις
Abstract
dc:descriptionNeutrophils are a major part of innate immunity. Through the formation of neutrophil extracellular traps (NETs) they are involved in the pathophysiology of various autoimmune, autoinflammatory and thrombotic conditions. In the context of different diseases, neutrophils release NETs that carry bioactive proteins, specific to each disease, determined by the inflammatory environment of the disease. Thromboinflammation is defined as the combination of inflammation with thrombosis. The interactions between neutrophils and platelets play an important role in this process. Thrombin-activated platelets are able to stimulate neutrophils. The NETs that are created have a key role in the establishment and expansion of the thrombosis. In addition, NETs carry tissue factor (TF) which is the major initiator of coagulation in vivo. This creates a vicious cycle (platelet / NETs / TF / thrombin) that enhances thromboinflammation. The models that this study is focused on are ulcerative colitis, systemic lupus erythematosus, myocardial infarction and COVID-19. The abovementioned models are characterized by thromboinflammation. Ulcerative colitis is a chronic inflammatory bowel disease with a variety of manifestations, such as thrombosis. During the present study it was found that the inflammatory microenvironment in both the peripheral blood and locally in the intestine appears to be capable of causing the release of NETs as well as the expression of TF in them. It has also been found that in systemic lupus erythematosus, a disease with many thrombotic complications, patients' neutrophils release NETs through the mechanism of autophagy. These NETs are decorated with bioactive TF. It is known from a previous study of our lab that in myocardial infarction the inflammatory environment of the disease in combination with activated platelets induces TF expression and its release through NETs. In the present study, it is indicated that ticagrelor is able to inhibit the formation of thrombogenic NETs induced either by platelet-neutrophil interaction (via polyP secretion) or by coronary stents, demonstrating the immunomodulatory potential of ticagrelor beyond of its antiplatelet activity. The SARS-CoV-2 infection causes thrombotic complications that affect multiple vital organs. NETs carrying bioactive TF were detected in COVID-19. It was further found that the release of NETs and TF expression is mediated by thrombin and complement system. The findings of this study suggest new alternative diagnostic or therapeutic strategies/ approaches. Drugs that target the production of TF and/or the mechanism of NET formation could be a treatment option in diseases characterized by thromboinflammation.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mitsios, Alexandros
- Μήτσιος, Αλέξανδρος
Subjects
dc:subject × 26- Ουδετερόφιλα
- Ουδετερόφιλο πολυμορφοπύρηνο λευκοκύτταρο
- Εξωκυττάριες παγίδες ουδετεροφίλων
- Φλεγμονώδεις παθήσεις
- Φλεγμονώδες ερέθισμα
- Θρόμβωση
- Φλεγμονώδης και θρομβωτική απάντηση
- Θρομβώσεις
- Συστηματικός ερυθηματώδης λύκος ( ΣΕΛ)
- Ελκώδης κολίτιδα
- Έμφραγμα του μυοκαρδίου
- COVID-19
- SARS-CoV-2
- Φλεγμονώδες περιβάλλον
- Neutrophils
- Neutrophil extracellular traps
- Inflammatory and thrombotic response
- Inflammatory diseases
- Inflammatory environment
- Thrombosis
- Systemic lupus erythematosus ( SLE)
- Ulcerative colitis
- Ιατρική και Επιστήμες Υγείας
- Άλλες Ιατρικές Επιστήμες
- Medical and Health Sciences
- Other Medical Sciences
Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48636